Epidemiology of complementary and alternative medicine therapy use in allogeneic hematopoietic stem cell transplant survivorship patients in Australia

This study demonstrates that a large proportion (54.1%) of HSCT survivors is using one or more form of complementary and alternative medical (CAM) therapies. Given the potential benefits demonstrated by small studies of particular CAM therapies in this patient group, as well as clearly documented therapies with no benefit or even toxicity, this result shows there is a large unmet need for additional studies to ascertain efficacy and safety of CAM therapies in this growing population.
Source: Cancer Medicine - Category: Cancer & Oncology Authors: Tags: Original Research Source Type: research